[go: up one dir, main page]

AR020158A1 - Mejorador del factor de induccion para la diferenciacion celular - Google Patents

Mejorador del factor de induccion para la diferenciacion celular

Info

Publication number
AR020158A1
AR020158A1 ARP990104011A ARP990104011A AR020158A1 AR 020158 A1 AR020158 A1 AR 020158A1 AR P990104011 A ARP990104011 A AR P990104011A AR P990104011 A ARP990104011 A AR P990104011A AR 020158 A1 AR020158 A1 AR 020158A1
Authority
AR
Argentina
Prior art keywords
cell differentiation
induction factor
factor improver
improver
optionally substituted
Prior art date
Application number
ARP990104011A
Other languages
English (en)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AR020158A1 publication Critical patent/AR020158A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/67Phosphorus compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invencion provee un mejorador de factor de induccion de diferenciacion celular que comprende un compuesto de formula (1), en donde el anillo A es unanillo de benceno opcionalmente sustituido; R es un átomo de hidrogeno o un grupo hidrocarburo opcionalmente sustituido; B es un grupo carboxiloopcionalmente esterificado o amidado; X es -CH(OH)- o -CO-; k es 0 o 1; y k es 0, 1 o 2; o su sal, que puede ser ventajosamente usado comoun mejorador de factor de induccion de diferenciacion celular.
ARP990104011A 1998-08-12 1999-08-11 Mejorador del factor de induccion para la diferenciacion celular AR020158A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22830098 1998-08-12

Publications (1)

Publication Number Publication Date
AR020158A1 true AR020158A1 (es) 2002-04-10

Family

ID=16874304

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990104011A AR020158A1 (es) 1998-08-12 1999-08-11 Mejorador del factor de induccion para la diferenciacion celular

Country Status (5)

Country Link
EP (1) EP1105140A2 (es)
AR (1) AR020158A1 (es)
AU (1) AU5196099A (es)
CA (1) CA2340165A1 (es)
WO (1) WO2000009100A2 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69132651T2 (de) * 1990-05-30 2001-10-25 Takeda Chemical Industries, Ltd. Schwefel enthaltende heterocyclische Verbindungen
TW403757B (en) * 1994-12-28 2000-09-01 Takeda Chemical Industries Ltd Optically active benzothiepin derivative, its preparation and use
WO1996025929A1 (en) * 1995-02-21 1996-08-29 Takeda Chemical Industries, Ltd. Use of helioxanthin as an enhancer of cell differentiation inducing factors
NZ308658A (en) * 1995-06-05 1999-10-28 Takeda Chemical Industries Ltd Sustained release synergistic pharmaceutical composition comprising a non-peptide osteogenetic promoting substance and a biodegradable polymer
CA2264131A1 (en) * 1996-08-26 1998-03-05 Takeda Chemical Industries, Ltd. Pharmaceutical composition containing osteogenesis-promoting substance
DE69721794T2 (de) * 1996-09-06 2004-03-18 Takeda Chemical Industries, Ltd. Kondensierte 4,5,6,7-tetrahydrobenzo c]thiophene als beschleuniger der wirkung des zelldifferenzierungsinduktionsfaktors

Also Published As

Publication number Publication date
AU5196099A (en) 2000-03-06
EP1105140A2 (en) 2001-06-13
CA2340165A1 (en) 2000-02-24
WO2000009100A3 (en) 2000-08-24
WO2000009100A2 (en) 2000-02-24

Similar Documents

Publication Publication Date Title
NO992375D0 (no) FremgangsmÕte for fremstilling av benzylethere
CO4780028A1 (es) Procedimiento para la preparacion de sildenafil
EE03194B1 (et) Ühendid, nende kasutamine magustavate toimeainetena ja nende valmistamise meetod
ATE218859T1 (de) Liganden des neuropeptids y
EP1122297A3 (en) Lubricant composition
ES2142123T3 (es) Derivados de organosiloxanilo de alcanodiol-monovinil-eteres, proceso para su preparacion, su modificacion y su empleo como aditivos para barnices.
DE69724422D1 (de) Arylalkylpiperazin-verbindungen als antioxidantien
ES2060578T3 (es) Sintesis de compuestos tipo podofilotoxina.
DK0460488T3 (da) Svovlholdige heterocykliske forbindelser
ES2155991T3 (es) Nuevos compuestos de terfenilo y medicamentos que contienen estos compuestos.
ES2017596T3 (es) Un nuevo proceso para intermediarios de carbapen.
BR9509741A (pt) Composto e uso de composto
NO953420L (no) Oksa- eller tiaalifatiske broinneholdende chinoksalin-2-dioner
AR020158A1 (es) Mejorador del factor de induccion para la diferenciacion celular
ATE209205T1 (de) Indan-2-mercaptoacetylamid disulfidderivate als enkephalinase inhibitoren
EA200001036A1 (ru) Способы ингибирования mrp1
ES8801669A1 (es) Un procedimiento para preparar nuevos compuestos de 2-oxa-0 aza-pregnano.
AR019664A1 (es) Composicion para el tratamiento de enfermedades del cartilago
BR0007897A (pt) Uso de derivados anticonvulsivantes para otratamento de bulimia nervosa
PT1206448E (pt) Novos analogos de vitamina d
ES8301872A1 (es) Un procedimiento para la preparacion de nuevos derivados de 4-2-hidroxi-4(sustituido) fenil-naftalen-2-1h-onas y 2-oles.
ES2077321T3 (es) Procedimiento para la obtencion de 2,2-bis-hidroximetil-butanodiol-(1,4).
ES2090777T3 (es) Procedimiento para el curtido de cuero y pieles.
ES2110839T3 (es) Copolimeros a base de dicetenos, acidos dicarboxilicos, o bien derivados de acidos dicarboxilicos etilenicamente insaturados, e hidrocarburos etilenicamente insaturados.
BR9714825A (pt) Composição fluoroquìmica para o tratamento de couro, processo de tratamento de couro, uso de uma composição fluoroquìmica, produto de reação de um polidieno enxertado, e, sal do produto de reação